Icy Hot Lidocaine No Mess Applicator Plus Menthol 4 % Gel is a Health Canada–registered human drug (DIN 02520052) held by Sanofi Consumer Health Inc, containing Lidocaine Hydrochloride. Health Canada lists its status as Approved (status date 09 Sep 2021). Nexara Health has matched 1836 registrations of Lidocaine Hydrochloride across 31 other regulated markets, 11 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02520052 |
|---|---|
| Brand name | Icy Hot Lidocaine No Mess Applicator Plus Menthol |
| Active ingredient | Lidocaine Hydrochloride |
| Strength | 4 % |
| Dosage form | Gel |
| Route | Topical |
| Company | Sanofi Consumer Health Inc |
| Status | Approved — 09 Sep 2021 |
| Class | Human |
| ATC | |
| AHFS | 56:12.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Lidocaine Hydrochloride registered in other markets
1836 registrations of the same molecule in 31 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Iceland | Lmx 4 | Parlogis - óskráð lyf | 4 % | krem | 0 | Lyfjastofnun lyfjaverdskra |
| Taiwan | Lidocaine Solution 4%“Yihhaw” | 利達製藥股份有限公司 | 外用液劑 | Registered | TFDA | |
| United Kingdom | Lidocaine 4% cream | — | 0001 | NHS dm+d VMP | ||
| United States | Black Cobra 4% Lidocaine Numbing Cream | Blackcobrasupply, LLC | Cream | FDA NDC | ||
| United States | Black Cobra Tattoo Numbing Cream 4% Lidocaine | Foshan Sugar Max Cosmetics CO.,Ltd | Cream | listed | FDA NDC | |
| United States | HealthWise 4% Lidocaine Cream | Veridian Healthcare | Cream | listed | FDA NDC | |
| United States | HealthWise 4% Lidocaine Cream 2.7 oz | Veridian Healthcare | Cream | listed | FDA NDC | |
| United States | Hempvana Ultra Strength Pain Relief Cream Platinum 4% Lidocaine | Telebrands Corp | Cream | listed | FDA NDC | |
| United States | Hunter Beach 4% | Hunters Beach Life | Gel | listed | FDA NDC | |
| United States | Hunter Beach 4% | Hunters Beach Life | Lotion | listed | FDA NDC | |
| United States | Lidocaine 4% | Innovida Pharmaeutique Corporation | Cream | listed | FDA NDC | |
| Australia | Lignocaine Injection (Bridgewest) | Wz | Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL | DB | PBS | |
| Australia | Xylocaine Viscous | As | Solution containing lidocaine hydrochloride 20 mg per mL (2%), 200 mL | R1 | PBS | |
| Australia | Xylocard 500 | As | Infusion containing lidocaine hydrochloride 500 mg in 5 mL | GE | PBS | |
| Austria | Cathejell Lidocain 2 % Gel | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Xylocain 2 % Amp. | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Xylocain Gel | — | 30ml | green box | eEKO (Erstattungskodex) | |
| Austria | Xyloneural Amp. | — | 5St | green box | eEKO (Erstattungskodex) | |
| Bahrain | 1% Lidocaine HCl | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 1 % W/V | Solution For Injection | POM | NHRA |
| Bahrain | 2% Lidocaine HCl | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 2 % | Solution For Injection | POM | NHRA |
| Bahrain | 2% Lidocaine HCl | Pharmaceutical Solution Industry Ltd (Psi), Ksa. | 2 % W/V | Solution For Injection | POM | NHRA |
| Bahrain | Avocaine | Middle East Pharmaceutical Industries Co. Ltd (Avalon Pharma), Ksa. | 10 % | Cutaneous Spray | POM | NHRA |
| Bahrain | Ledo | Batterjee Pharmaceutical Factory, Ksa. | 50 MG/GM | Ointment | POM | NHRA |
| Bahrain | Lidgucaine | Gulf Biotech Bsc (Closed), Bahrain. | 1 % | Solution For Injection | POM | NHRA |
| Bahrain | Lidocaine | Gulf Pharmaceutical Industries (Julphar), Uae. | 5 % | Ointment | POM | NHRA |
| Bahrain | Lidocaine HCl | Gulf Inject LLC, Uae. | 2 % | Solution For Injection | POM | NHRA |
| Bulgaria | Doxiproct | OMEDICAMED Unipessoal Lda | 40 mg/20 mg/g ointment | маз | По лекарско предписание | BDA |
| Bulgaria | Instillido | Farco-Pharma GmbH | 20 mg/ml gel | гел | По лекарско предписание | BDA |
| Bulgaria | Lidocain - EGIS | EGIS Pharmaceutical PLC | 4,6 mg /dose cutaneous spray, solution | спрей дермален, разтвор | По лекарско предписание | BDA |
| Bulgaria | Lidocain Actavis | Тева Фарма ЕАД | 5% ointment | маз | По лекарско предписание | BDA |
| Bulgaria | Lidocain Danhson | Дансон-Бг Оод | 10 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Lidocain Danhson | Дансон-Бг Оод | 20 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Lidocaine Grindeks | As Grindeks | 20 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Lidocaine Grindeks | AS Grindeks | 10 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Croatia | Dolokain gel | Jadran - Galenski Laboratorij d.d. | gel 1x25 g (20 mg/1 g) | HZZO | ||
| Croatia | lidokain | — | HZZO | |||
| Croatia | Lidokain Belupo | Belupo d.d. | otop. za rasprš. 50 ml (100 mg/1 ml) | HZZO | ||
| Croatia | Lidokainklorid B. Braun 20 mg/ml | B. Braun Adria d.o.o. | otop. za inj./inf., 20 mg/ml, polietil. amp. 20x10 ml | HZZO | ||
| Croatia | Lidokainklorid B. Braun 20 mg/ml | B. Braun Adria d.o.o. | otop. za inj./inf., 20 mg/ml, polietil. amp. 20x5 ml | HZZO | ||
| Croatia | Lidokainklorid Belupo | Belupo d.d. | amp. 5x100 mg/5 ml | HZZO | ||
| Croatia | Lidokainklorid Belupo | Belupo d.d. | amp. 100x40 mg/2 ml | HZZO | ||
| Croatia | Versatis | Grünenthal GmbH | flaster med. 5%, 10x(10 cmx14 cm)/700 mg | R | HZZO | |
| Czech Republic | Emla | — | 25MG/G+25MG/G | Crm | R | SUKL DLP |
| Czech Republic | Fortacin | — | 150MG/ML+50MG/ML | Drm Spr Sol | R | SUKL DLP |
| Czech Republic | Fortacin | — | 150MG/ML+50MG/ML | Drm Spr Sol | R | SUKL DLP |
| Czech Republic | Lidocaine Egis | — | 10% | Drm Spr Sol | R | SUKL DLP |
| Czech Republic | Lidocaine Egis | — | 20MG/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Lidocaine Noridem | — | 20MG/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Lidocaine Noridem | — | 10MG/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Versatis | — | 700MG | Emp Med | R | SUKL DLP |
| Denmark | Lidokain "SAD" | Amgros I/S | 20 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Lidokain "SAD" | Amgros I/S | 10 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Lidokain "SAD" | Amgros I/S | 5 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Lidoposterin | Epione Medicine ApS | 50 mg/g | rektalsalve | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Lidoposterin | XGX Pharma ApS | 50 mg/g | rektalsalve | MRP | Laegemiddelstyrelsen |
| Denmark | Lidor Vet. | VetViva Richter GmbH | 20 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Lignovet | ScanVet Animal Health A/S | 19 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Versatis | Orifarm A/S | 700 mg | medicinsk plaster | Par-Imp | Laegemiddelstyrelsen |
| Greece | CONSOLID® INJ.SOL 20MG/ML BTx 6 amp x5 ml (σε θήκη από PVC & Aluminium foil) | Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε | reimbursed | MoH deltio timwn | ||
| Greece | CONSOLID® INJ.SOL 20MG/ML BTx5 amp x5 ml (σε θήκη από PVC & Aluminium foil) | Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε | reimbursed | MoH deltio timwn | ||
| Greece | INTERMED XYLOJELL SPR 10% W/V BTx1 FLx50 ML (Γυάλινο φιαλίδιο+μηχανική αντλία ψεκασμού με δοσομετρική βαλβίδα+πλαστικό ρύγχος ψεκασμού) | Ιουλ.& Ειρ. Τσετη Φαρ/Κα Εργαστηρια Αβεε Δ.τ."Intermed Abee" | reimbursed | MoH deltio timwn | ||
| Greece | INTERMED XYLOJELL® GEL.EXT.US 2% W/W BTx1 TUBEx30 g | Ιουλ.& Ειρ. Τσετη Φαρ/Κα Εργαστηρια Αβεε Δ.τ."Intermed Abee" | reimbursed | MoH deltio timwn | ||
| Greece | VERSATIS MED.PLAST 700mg BTx1 SACHET x 5 PLASTERS (5 PLASTERS) | Grunenthal GmbH, Germany | reimbursed | MoH deltio timwn | ||
| Greece | VERSATIS MED.PLAST 700mg BTx4 SACHETS x 5 PLASTERS (20 PLASTERS) x 5 PLASTERS (20 PLASTERS) | Grunenthal GmbH, Germany | reimbursed | MoH deltio timwn | ||
| Greece | XYLOCAINE GEL.EXT.US 2% W/W TUBx30G | Aspen Pharma Trading Limited, Ireland | reimbursed | MoH deltio timwn | ||
| Greece | XYLOCAINE SPR 10% W/V FLx50ML(500 DOSES) | Aspen Pharma Trading Limited, Ireland | reimbursed | MoH deltio timwn | ||
| Hong Kong | Anacaine Inj 2% | Kai Yuen Pharmaceutical Co | Registered | DH Drug Office | ||
| Hong Kong | Axcel Lignocaine Gel 2%W/W | Kotra Pharma (Hong Kong) Company | Registered | DH Drug Office | ||
| Hong Kong | Bf-Lidocaine Ointment 5% W/W | Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited | Registered | DH Drug Office | ||
| Hong Kong | L.m.x.4 Topical Anesthetic Cream 4%W/W | Hong Wo Pharmaceutical Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Lido-Anes Spray 10% | Main Life Corp Ltd | Registered | DH Drug Office | ||
| Hong Kong | Lidocaine HCl Inj 1% | Yat Seng Trading Co | Registered | DH Drug Office | ||
| Hong Kong | Lidocaine Kabi Solution For Injection 50mg/5ml | Fresenius Kabi Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Lidomed Injection 2%W/V | Lafarge Co., Limited | Registered | DH Drug Office | ||
| Iceland | Acoin Lidocainhydrochlorid | Parlogis - óskráð lyf | 40 mg/ml | spray | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | BelOcain vet. | Bela-Pharma GmbH & CO KG | 20 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Lat | Parlogis - óskráð lyf | 4 % | hlaup | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Lidocain m.dextrose | Parlogis - óskráð lyf | irl | 0 | Lyfjastofnun lyfjaverdskra | |
| Iceland | Lidokain Viatris | Mylan Ireland Limited | 20 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Lidokain Viatris | Mylan Ireland Limited | 10 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Iceland | Lidokain Viatris | Mylan Ireland Limited | 10 mg/ml | stl | 2 | Lyfjastofnun lyfjaverdskra |
| Ireland | 1% w/v Lidocaine Hydrochloride Injection BP | B. Braun Melsungen AG | Solution for injection | Marketed | HPRA | |
| Ireland | 2% w/v Lidocaine Hydrochloride Injection BP | B. Braun Melsungen AG | Solution for injection | Marketed | HPRA | |
| Ireland | Dolocopin 40mg/g Cream | Ferndale Laboratories Limited | Cream | Not marketed | HPRA | |
| Ireland | Lidocaine 10 mg/ml (1% w/v) solution for injection in pre-filled syringe | Laboratoire Aguettant | Solution for injection in pre-filled syringe | Marketed | HPRA | |
| Ireland | Lidocaine 20 mg/ml (2% w/v) solution for injection in pre-filled syringe | Laboratoire Aguettant | Solution for injection in pre-filled syringe | Not marketed | HPRA | |
| Ireland | Lidocaine Hydrochloride 1% w/v Solution for Injection | Fresenius Kabi Deutschland GmbH | Solution for injection | Marketed | HPRA | |
| Ireland | Lidocaine Hydrochloride 2% w/v Solution for Injection | Fresenius Kabi Deutschland GmbH | Solution for injection | Marketed | HPRA | |
| Ireland | Lidocaine hydrochloride 20 mg/ml, solution for injection/infusion | Laboratoire Aguettant | Solution for injection/infusion | Not marketed | HPRA | |
| Lebanon | Lidocaine Hydrochloride 1% | Tabuk Pharmaceutical Manufacturing Company | 10mg/ml | Injection | B | MoPH |
| Luxembourg | INSTILLAGEL GEL 1*1 seringue 11 mL | — | RR | CNS liste positive | ||
| Luxembourg | INSTILLAGEL GEL 1*1 seringue 6 mL | — | RR | CNS liste positive | ||
| Luxembourg | INSTILLAGEL GEL 1*10 seringues 11 mL | — | RR | CNS liste positive | ||
| Luxembourg | INSTILLAGEL GEL 1*10 seringues 6 mL | — | RR | CNS liste positive | ||
| Luxembourg | Versatis Emplatre Med. 5 Pc 1*10 Emplatres | — | R | CNS liste positive | ||
| Luxembourg | Versatis Emplatre Med. 5 Pc 1*30 Emplatres | — | R | CNS liste positive | ||
| Luxembourg | XYLOCAINE GEL URETRAL 2 PC 1*1 tube 30 mL | — | P | CNS liste positive | ||
| Luxembourg | XYLOCAINE POMM. 5 PC 1*1 tube 35 g | — | P | CNS liste positive | ||
| MA | Lidocaine 1% Laprophan | — | 1 % | Solution Injectable | G | CNOPS liste des medicaments |
| MA | Lidocaine 2% Laprophan | — | 2 % | Solution Injectable | G | CNOPS liste des medicaments |
| MA | Lidocaine 2% Visqueuse Laprophan | — | 2 % | Gel Buccal | G | CNOPS liste des medicaments |
| MA | Lidocaine 5% Laprophan | — | 5 % | Solution Pour Application Locale | G | CNOPS liste des medicaments |
| MA | Xylocaine 5% Nebuliseur | — | 5 % | Solution Pour Inhalation | P | CNOPS liste des medicaments |
| MA | Xylocaine Visqueuse | — | 2 % | Gel Buccal | P | CNOPS liste des medicaments |
| MA | Zaicaïne 2 % Noradrenaline | — | 38.412 MG | Solution Injectable Pour Usage Dentaire | P | CNOPS liste des medicaments |
| MA | Ziacaine 2 % Speciale | — | 36 MG | Solution Injectable Pour Usage Dentaire | P | CNOPS liste des medicaments |
| Malaysia | Lakan Injection 1% (10ml Vial) | Duopharma (M) Sendirian Berhad | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Lakan Injection 2% (10ml Vial) | Duopharma (M) Sendirian Berhad | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Lidonostrum 10% w/v Topical Spray | Schmidt Biomedtech Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Locana Injection | Healol Pharmaceuticals Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | OXACAIN (Lidocaine 10% Oromucosal Spray) | Medispec (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Xylocaine 2% Mdv | Aspen Medical Products Malaysia Sdn Bhd | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malta | Versatis Medicated Plaster 700mg | Grunenthal GmbH | Medicated Plaster | Withdrawn | Medicines Authority | |
| Malta | Xylocaine 10 mg/delivered dose Mucosal Spray | Aspen Pharma Trading Limited | Cutaneous Spray | Authorised | Medicines Authority | |
| Netherlands | Lidocaïne vaselinecrème 3% DMB, crème 30 mg/g | Tiofarma B.V. | Crème | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Versatis 700 mg pleister | Grünenthal B.V. | Pleister | Uitsluitend recept | EU national register | |
| Netherlands | Xylocaine 10 mg/ml oplossing voor injectie | Aspen Pharma Trading Limited | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Xylocaine 100 mg/ml spray | Euro Registratie Collectief B.V. | Spray voor oromucosaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Xylocaine 100 mg/ml Spray, spray | EU-Pharma B.V. | Spray voor oromucosaal gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Xylocaine 100 mg/ml Spray, spray | Aspen Pharma Trading Limited | Spray voor oromucosaal gebruik | Uitsluitend recept | EU national register |
See every manufacturer of Lidocaine Hydrochloride worldwide →
Regulator price references for Lidocaine Hydrochloride
Published list or reimbursement prices for Lidocaine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Lmx 4 | 4pct | túpa | 4,670.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Australia | Xylocard 500 | Infusion containing lidocaine hydrochloride 500 mg in 5 mL | 20.55 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Lignocaine Injection (Bridgewest) | Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL | 34.82 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Xylocaine Viscous | Solution containing lidocaine hydrochloride 20 mg per mL (2%), 200 mL | 85.68 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Xyloneural Amp. | 5St | 3.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 | |
| Austria | Xylocain 2 % Amp. | 2pct | 5St | 5.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Xylocain Gel | 30ml | 30ml | 6.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Cathejell Lidocain 2 % Gel | 2pct | 5St | 12.45 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Lidocaine HCl | 2pct | 5 ML | 0.22 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lidocaine HCl | 2pct | 10 ML | 0.50 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Ledo | 50mg/1000mg | 20G | 0.51 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 1% Lidocaine HCl | 1pct | 20ML | 0.61 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Rialocaine | 2pct | 20G | 0.72 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lidocaine HCl | 2pct | 15 ML | 0.78 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 2% Lidocaine HCl | 2pct | 10ML | 0.79 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | 2% Lidocaine HCl | 2pct | 50ML | 0.84 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lidocaine | 5pct | 30G | 1.03 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Stud 100 Desensitizing Spray | 9.6pct | 12G | 1.78 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Avocaine | 10pct | 50ML | 2.54 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Xylocaine | 10pct | 50ML | 2.89 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Lidgucaine | 1pct | 20ML | 5.00 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Locan | 2pct | 1X 20ML | 5.00 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Versatis | 700mg | 5 | 10.52 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Versatis | 700mg | 30 | 48.46 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | INTERMED XYLOJELL® GEL.EXT.US 2% W/W BTx1 TUBEx30 g | 2pct+30000mg | 3.11 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CONSOLID® INJ.SOL 20MG/ML BTx5 amp x5 ml (σε θήκη από PVC & Aluminium foil) | 20mg/1ml | 3.91 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | XYLOCAINE GEL.EXT.US 2% W/W TUBx30G | 2pct+30000mg | 4.00 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CONSOLID® INJ.SOL 20MG/ML BTx 6 amp x5 ml (σε θήκη από PVC & Aluminium foil) | 20mg/1ml | 4.38 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | INTERMED XYLOJELL SPR 10% W/V BTx1 FLx50 ML (Γυάλινο φιαλίδιο+μηχανική αντλία ψεκασμού με δοσομετρική βαλβίδα+πλαστικό ρύγχος ψεκασμού) | 10pct+50ml | 4.83 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | XYLOCAINE SPR 10% W/V FLx50ML(500 DOSES) | 10pct+50ml | 7.17 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VERSATIS MED.PLAST 700mg BTx1 SACHET x 5 PLASTERS (5 PLASTERS) | 700mg | 9.05 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | XYLOZAN INJ.SOL 2% BTx5VIALSx50ML (γυάλινα φιαλίδια) | 2pct+50ml | 12.15 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | VERSATIS MED.PLAST 700mg BTx4 SACHETS x 5 PLASTERS (20 PLASTERS) x 5 PLASTERS (20 PLASTERS) | 700mg | 41.40 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Lidor vet. | 20mg/1ml | hgl | 1,194.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Lidokain Viatris | 10mg/1ml | hgl | 1,258.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Lidokain Viatris | 10mg/1ml | hgl | 1,258.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Xyloneural Forte | 2pct | hgl | 1,346.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Lidokain Viatris | 20mg/1ml | hgl | 1,407.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Xylocain | 10mg/1ml | hgl | 2,160.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Xylocain | 100mg/1ml | glas | 2,187.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Xylocain | 20mg/1ml | hgl | 2,549.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Acoin Lidocainhydrochlorid | 40mg/1ml | stk | 3,870.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Sulgan | 2pct | túpa | 4,505.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Sulgan | 4.3mg | pakki | 4,819.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Xylocard 100 mg/5 ml | 20mg/1ml | hgl | 9,344.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Lat | 4pct | túpa | 13,228.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | BelOcain vet. | 20mg/1ml | hgl | 15,300.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Versatis | 700mg | pakkar | 35,646.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Lidocain m.dextrose | pokar | 69,036.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Lebanon | Lidocaine Hydrochloride 1% | 10mg/1ml | 100Ampoules of 5ml | 66.07 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Luxembourg | INSTILLAGEL GEL 1*1 seringue 6 mL | 6ml | 3.04 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | INSTILLAGEL GEL 1*1 seringue 11 mL | 11ml | 3.55 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | XYLOCAINE POMM. 5 PC 1*1 tube 35 g | 35000mg | 6.78 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | XYLOCAINE GEL URETRAL 2 PC 1*1 tube 30 mL | 30ml | 7.51 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | XYLOCARD SOL.INJ. 2 % v/v 1*5 AMP. 5 ML | 2pct+5ml | 9.83 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | INSTILLAGEL GEL 1*10 seringues 6 mL | 6ml | 15.20 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | INSTILLAGEL GEL 1*10 seringues 11 mL | 11ml | 19.18 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | XYLOCAINE SOL.PULV.BUCC. 10 PC 1*1 flacon pulvérisateur 50 mL | 50ml | 23.70 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Versatis Emplatre Med. 5 Pc 1*10 Emplatres | 38.42 EUR | reimbursement | CNS liste positive | 2026-09-05 | ||
| Luxembourg | Versatis Emplatre Med. 5 Pc 1*30 Emplatres | 98.90 EUR | reimbursement | CNS liste positive | 2026-09-05 | ||
| MA | Lidocaine 1% Laprophan | 1pct | 1 FLACON 20 ML | 15.70 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lidocaine 2% Laprophan | 2pct | 1 FLACON 20 ML | 16.50 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lidocaine 5% Laprophan | 5pct | 1 FLACON 24 ML | 26.10 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Xylocaine Visqueuse | 2pct | 1 TUBE 100 G | 32.20 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Lidocaine 2% Visqueuse Laprophan | 2pct | 1 TUBE 100 G | 33.60 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Xylocaine 5% Nebuliseur | 5pct | 1 BOITE 1 FLACON | 146.10 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| United Arab Emirates | 1% w/v LIDOCAINE HYDROCHLORIDE INJECTION USP | 1pct | 20ml Glass Vial | 3.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lidocaine HCl 1% w/v MultiDose (10mg/ml) [Gulf Inject] | 1000mg/100ml | 50 ml LDPE Bottle (MultiDose) | 9.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lidocaine HCl 2% w/v MultiDose (20mg/ml) [Gulf Inject] | 20mg/1ml | 50 ml (Multi dose) LDPE Bottle | 14.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lidocaine HCl 1% w/v MultiDose (10mg/ml) [Gulf Inject] | 1000mg/100ml | 100 ml LDPE Bottle (MultiDose) | 16.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Avocaine Spray | 10pct | 50 ml Transparent glass bottle with Spray Pump | 22.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Xylocaine® 10% | 10pct | 50ml Bottle with Spray Pump | 29.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lidocaine HCl 2% w/v MultiDose (20mg/ml) [Gulf Inject] | 20mg/1ml | 100 ml (Multi dose) LDPE Bottle | 138.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Versatis ® 700 mg | 5pct | 5 Plasters (14cm x 10cm) | 145.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lidocaine HCl 1% w/v (Gulf Inject) | 1pct | 100 LDPE Ampoules (2 mL) | 357.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lidocaine HCl 1% w/v (Gulf Inject) | 1pct | 100 LDPE Ampoules (3.5 mL) | 417.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Lidocaine HCl 1% w/v (Gulf Inject) | 1pct | 100 LDPE Ampoules (4 mL) | 417.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | LIDOCAINE 20 mg/mL ADRENALINE 0.005 mg/mL AGUETTANT | 0.005mg/1ml+20mg/1ml | 10 Glass Ampoules (10 mL) | 510.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | LIDOCAINE 10 mg/mL ADRENALINE 0.005 mg/mL AGUETTANT | 0.005mg/1ml+10mg/1ml | 10 Glass Ampoules (10 mL) | 510.00 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Versatis ® 700 mg | 5pct | 30 Plasters (14cm x 10cm) | 592.50 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Icy Hot Lidocaine No Mess Applicator Plus Menthol (DIN 02520052) marketed in Canada?
No. Health Canada lists DIN 02520052 as Approved as of 09 Sep 2021.
Who holds the Canadian licence for this product?
Sanofi Consumer Health Inc is the company of record in the Health Canada Drug Product Database.
Is Lidocaine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 1836 registrations in 31 other markets, including 11 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02520052, status date 2021-09-09; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SUKL DLP, TFDA; price sources: CNOPS liste des medicaments, CNS liste positive, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02520052, status date 2021-09-09; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SUKL DLP, TFDA; price sources: CNOPS liste des medicaments, CNS liste positive, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, NHRA, PBS.
Sanofi Consumer Health Inc — company profileWho else makes Lidocaine HydrochlorideAll Canadian Lidocaine Hydrochloride products
Health Canada Drug Product Database (DPD), DIN 02520052, status date 2021-09-09; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, MoPH, NHRA, NHS dm+d VMP, NPRA, PBS, SUKL DLP, TFDA; price sources: CNOPS liste des medicaments, CNS liste positive, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, NHRA, PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.